PSBJ Interview: Fred Hutch veteran Dr. Carla Grandori is flipping the script on cancer treatment


Grandori's company SEngine, is preparing for a future in which cancer is not going to be treated according to cancer type – like breast or colon – but it will be treated based on its genetic underpinning.

Previous 5 good reads: Cerner CEO's new plan, Sprint lobbies Congress
Next Saving lives provides worthwhile — if expensive — work for life sciences companies